Contribution of GRB10 to the prenatal phenotype in Silver-Russell syndrome? Lessons from 7p12 copy number variations.


Journal

European journal of medical genetics
ISSN: 1878-0849
Titre abrégé: Eur J Med Genet
Pays: Netherlands
ID NLM: 101247089

Informations de publication

Date de publication:
Jul 2019
Historique:
received: 11 12 2018
revised: 07 05 2019
accepted: 12 05 2019
pubmed: 18 5 2019
medline: 5 9 2019
entrez: 18 5 2019
Statut: ppublish

Résumé

The growth factor binding protein 10 (GRB10) has been suggested as a candidate gene for Silver-Russell syndrome because of its localization in 7p12, its imprinting status, data from mice models and its putative role in growth. Based on a new patient with normal growth carrying a GRB10 deletion affecting the paternal allele and data from the literature, we conclude that the heterogeneous clinical findings in patients with copy number variations (CNVs) of GRB10 gene depend on the size and the gene content of the CNV. However, evidence from mouse and human cases indicate a growth suppressing role of GRB10 in prenatal development. As a result, an increase of active maternal GRB10 copies, e.g. by maternal uniparental disomy of chromosome 7 or duplications of the region results in intrauterine growth retardation. In contrast, a defective GRB10 copy might result in prenatal overgrowth, whereas the paternal GRB10 allele is not required for proper prenatal growth.

Identifiants

pubmed: 31100449
pii: S1769-7212(18)30914-5
doi: 10.1016/j.ejmg.2019.103671
pii:
doi:

Substances chimiques

GRB10 protein, human 0
GRB10 Adaptor Protein 151441-47-3

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

103671

Informations de copyright

Copyright © 2019. Published by Elsevier Masson SAS.

Auteurs

Thomas Eggermann (T)

Institute of Human Genetics, University Hospital, Technical University Aachen (RWTH), Aachen, Germany. Electronic address: teggermann@ukaachen.de.

Matthias Begemann (M)

Institute of Human Genetics, University Hospital, Technical University Aachen (RWTH), Aachen, Germany.

Ingo Kurth (I)

Institute of Human Genetics, University Hospital, Technical University Aachen (RWTH), Aachen, Germany.

Miriam Elbracht (M)

Institute of Human Genetics, University Hospital, Technical University Aachen (RWTH), Aachen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH